Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer

Clinical trial NCT01101334 · COMPLETED

Trial details

NCT number: NCT01101334
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer (NSCLC)

Start date: 2010-03-01
Primary completion: 2013-04-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.